switching from ozempic to retatrutide Can You Take and Together? switch from semaglutide to retatrutide

Most prior obesity trials run 6872 weeks

In Phase 2 trials over 48 weeks, participants at the 12mg dose achieved an average of 24.2% body weight reduction, outpacing both Semaglutide (14.9%) and Tirzepatide (20.9%) in comparative data

If the Phase 2a results hold, retatrutide could become the first truly effective pharmaceutical treatment for this condition

GLP-1 receptor agonists work through several mechanisms: they enhance insulin secretion when blood glucose levels are elevated, suppress glucagon release (which reduces glucose production by the liver), slow gastric emptying, and promote satiety through effects on appetite centres in the brain